HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No evidence of cross-reactivity of human antibodies to a 33-mer peptide of the alpha-gliadin component of gluten with Bordetella pertussis pertactin.

Abstract
A 33-mer peptide of the alpha-gliadin component of gluten was recently identified as primary initiator of the inflammatory response to gluten in coeliac disease (CD) patients. This proline-glutamine-rich peptide (PG-peptide) is highly homologous to internal sequence of pertactin, an immunogenic protein of Bordetella pertussis. Using enzyme immunoassays, we measured serum antibodies to pertactin and to PG-peptide in 167 Finnish subjects including pertussis vaccine recipients and pertussis patients, CD and non-CD patients and healthy individuals. We found no cross-reactivity between human antibodies to the two different components, suggesting that neither pertussis immunization nor disease contributes to the pathogenesis of CD.
AuthorsQiushui He, Matti K Viljanen, Ari E Hinkkanen, Heikki Arvilommi, Jussi Mertsola, Markku Viander
JournalVaccine (Vaccine) Vol. 23 Issue 25 Pg. 3336-40 (May 09 2005) ISSN: 0264-410X [Print] Netherlands
PMID15837240 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Bacterial
  • Bacterial Outer Membrane Proteins
  • Immunoglobulin A
  • Immunoglobulin G
  • Virulence Factors, Bordetella
  • pertactin
  • Glutens
  • Gliadin
Topics
  • Adolescent
  • Adult
  • Antibodies, Bacterial (analysis, biosynthesis)
  • Antibody Specificity
  • Bacterial Outer Membrane Proteins (chemistry, immunology)
  • Bordetella pertussis (chemistry, immunology)
  • Child
  • Child, Preschool
  • Cross Reactions
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Finland
  • Gliadin (immunology)
  • Glutens (immunology)
  • Humans
  • Immunoglobulin A (analysis, immunology)
  • Immunoglobulin G (analysis, immunology)
  • Male
  • Middle Aged
  • Virulence Factors, Bordetella (chemistry, immunology)
  • Whooping Cough (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: